A top-10 list of critical legal issues that biotech start-ups should make an effort to address, even when the capital squeeze is intense.
Jennifer S. Geetter
Advertisement
Jennifer S. Geetter is a partner at McDermott Will & Emery
Articles by Jennifer S. Geetter
Advertisement
Latest Updated Articles
- Top 10 Legal Issues Biotech Start-Ups Must Address
Published: November 1st 2008 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Biologics, Obesity, China Top Financial Trends Reshaping Pharma R&D in J.P. Morgan Report
2
Biotech Equipment Market to Approach $144B by 2030: Implications for Pharma R&D
3
CGT Innovations: The Three-Pronged Strategy for Industry Growth (Part 2)
4
Strategies for Building Tech Talent in the Biopharma Industry (Part 4)
5
